# Evonik stock faces Jefferies downgrade as takeover focus grows

> Jefferies downgraded Evonik to Hold from Buy on November 11, 2026, and cut its 2027 EBITDA forecast by 9 percent to below 2 billion euros. The brokerage said the earnings boost from Middle East supply disruptions is fading, and methionine prices have fallen 43 percent from their April peak in China, 31 percent in Europe and 15 percent in the United States. Evonik shares traded at 20.94 euros on November 12.

- Date: 2026-11-12 · published 2026-11-12T15:11:15.748Z
- Category: market · region Global · magnitude low
- Page: https://feedsoft.ai/events/95697-evonik-stock-faces-jefferies-downgrade-as-takeover-focus-grows
- Commodities: [Methionine](https://feedsoft.ai/c/METH.md)

## Why it matters

Methionine is a key feed amino acid, so its falling prices from the post-Hormuz peak point to easing costs for feed makers. The downgrade signals that the supply-driven price support is fading.

## Read by commodity

- METH: bearish ▼

## Sources

- ad-hoc-news.de: https://www.ad-hoc-news.de/boerse/news/corporate-news/evonik-stock-faces-jefferies-downgrade-as-takeover-focus-grows/70497174

---
Data from Feedsoft AI (https://feedsoft.ai/). For information only; not investment advice.